Circadian Rhythm Sleep Disorders Market
- 2026 年市場規模
- USD 2.7 Bn
- 2033 年預估規模
- USD 4.23 Bn
- 年複合成長率 CAGR
- 6.8%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Circadian Rhythm Sleep Disorders Market, By Treatment Type (Healthy Lifestyle Changes, Bright Light Therapy, and Melatonin), By Application Type (Delayed Sleep Phase Disorder, Advanced Sleep Phase Disorder, Jet Lag, Shift Work Disorder, Irregular Sleep Wake Rhythm, and Non-24-hour Sleep-Wake Syndrome), By Distribution Channel (Institutional Sales and Retail Sales), By Drug (Melatonin, Modafinil, and Tasimelteon), By End User (Hospitals, Home Care Settings, and Sleep Centers), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
報告摘要
The Circadian Rhythm Sleep Disorders Market is estimated to be valued at USD 2.7 Bn in 2026 and is expected to reach USD 4.23 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 6.8% from 2026 to 2033. The market is undergoing a major transformation mainly driven by rising awareness of sleep health, improved diagnostic capabilities, and growing demand for effective chronotherapy treatments. Circadian rhythm sleep disorders, including delayed sleep phase disorder, advanced sleep phase disorder, and non-24-hour sleep-wake disorder, disrupt the natural sleep-wake cycle and may lead to severe complications like impaired cognitive performance, mood disorders, and metabolic dysfunction if left untreated. The market includes a wide array of treatment options like light therapy, melatonin receptor agonists, behavioral interventions, combination therapies, and supportive care products.
Healthcare providers are increasingly focusing on early diagnosis and targeted treatment to restore circadian alignment and prevent recurrence. The advancements in wearable sleep trackers, actigraphy, and home-based polysomnography are improving case detection, especially in regions with limited access to specialized sleep clinics. In addition, the growing use of combination therapy helps optimize sleep timing and quality, thereby improving treatment outcomes and lowering relapse risk.
Market Dynamics
The Circadian Rhythm Sleep Disorders Market is witnessing a major momentum owing to the rising prevalence of sleep-wake misalignment disorders and lifestyle-induced circadian disruptions. The market’s growth is largely attributed to the growing need for targeted therapeutic interventions, especially in shift workers, adolescents, and elderly populations who face higher risks of sleep deprivation and metabolic complications. Chronobiotic medications, light therapy devices, and behavioral sleep interventions play a central role in disorder management, thereby helping reduce symptoms like excessive daytime sleepiness, mood disturbances, and cognitive impairments. The rising focus on early diagnosis, personalized treatment, and public awareness is strengthening the demand for reliable Circadian Rhythm Sleep Disorders solutions.
The expansion of sleep medicine infrastructure is fueling market growth. This is mainly driven by the increasing adoption of wearable sleep monitoring, telemedicine-based consultations, and wider availability of prescription therapies like melatonin agonists, ramelteon, tasimelteon, and agomelatine. Combination approaches involving pharmacological and behavioral strategies improve circadian alignment and reduce relapse risk.
The rising demand for optimized sleep health is also propelling the market. Sleep clinics, hospitals, research institutions, and wellness centers play a crucial role in identifying and managing sleep disorders. As awareness of circadian health grows, the market is expected to benefit from better patient adherence, improved clinical outcomes, and the development of safer, more targeted sleep disorder therapies.
Key Features of the Study
• This report provides in-depth analysis of the Circadian Rhythm Sleep Disorders Market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Circadian Rhythm Sleep Disorders Market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Vanda Pharmaceuticals, Aeroflow, Inc., Cephalon, Inc., Takeda Pharmaceutical Company, Teva Pharmaceutical Industries Ltd., Mylan N.V., The Sunbox Company, Verilux, Inc., Northern Light Technologies, Koninklijke Philips N.V., and Amjo Corp.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Circadian Rhythm Sleep Disorders Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Circadian Rhythm Sleep Disorders Market
Market Segmentation
• Treatment Type Insights (Revenue, USD Bn, 2026-2033)
o Healthy Lifestyle Changes
o Bright Light Therapy
o Melatonin
• Application Type Insights (Revenue, USD Bn, 2026-2033)
o Delayed Sleep Phase Disorder
o Advanced Sleep Phase Disorder
o Jet Lag
o Shift Work Disorder
o Irregular Sleep Wake Rhythm
o Non-24-hour Sleep-wake Syndrome
• Distribution Channel Insights (Revenue, USD Bn, 2026-2033)
o Institutional Sales
o Retail Sales
• Drug Insights (Revenue, USD Bn, 2026-2033)
o Melatonin
o Modafinil
o Tasimelteon
• End User Insights (Revenue, USD Bn, 2026-2033)
o Hospitals
o Home Care Settings
o Sleep Centers
• Regional Insights (Revenue, USD Bn, 2026 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
U.K.
Germany
Italy
France
Russia
Spain
Rest of Europe
o Asia Pacific
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
North Africa
Central Africa
South Africa
• Key Players Insights
o Vanda Pharmaceuticals
o Aeroflow, Inc.
o Cephalon, Inc.
o Takeda Pharmaceutical Company
o Teva Pharmaceutical Industries Ltd.
o Mylan N.V.
o The Sunbox Company
o Verilux, Inc.
o Northern Light Technologies
o Koninklijke Philips N.V.
o Amjo Corp.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Treatment Type
Market Snapshot, By Application Type
Market Snapshot, By Distribution Channel
Market Snapshot, By Drug
Market Snapshot, By End User
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Product Approval
o Collaboration/Merge/Acquisition
o Regulatory Landscape
o PEST Analysis
o Porter’s Five Forces Analysis
o Epidemiology
o Robust Pipeline Analysis
4. Global Circadian Rhythm Sleep Disorders Market, By Treatment Type, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Healthy Lifestyle Changes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Bright Light Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Melatonin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
5. Global Circadian Rhythm Sleep Disorders Market, By Application Type, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Delayed Sleep Phase Disorder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Advanced Sleep Phase Disorder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Jet Lag
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Shift Work Disorder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Irregular Sleep Wake Rhythm
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Non-24-hour Sleep-wake Syndrome
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
6. Global Circadian Rhythm Sleep Disorders Market, By Distribution Channel, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Institutional Sales
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Retail Sales
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
7. Global Circadian Rhythm Sleep Disorders Market, By Drug, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Melatonin
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Modafinil
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Tasimelteon
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
8. Global Circadian Rhythm Sleep Disorders Market, By End User, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Home Care Settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
o Sleep Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
9. Global Circadian Rhythm Sleep Disorders Market, By Region, 2021 – 2033, (USD Billion)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Application Type, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Drug, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Billion)
o North Africa
o Central Africa
o South Africa
10. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profile
Vanda Pharmaceuticals
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Aeroflow, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Cephalon, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Takeda Pharmaceutical Company
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Teva Pharmaceutical Industries Ltd.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Mylan N.V.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
The Sunbox Company
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Verilux, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Northern Light Technologies
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Koninklijke Philips N.V.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Amjo Corp.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
o Analyst Views
11. Section
o References
o Research Methodology
o About Us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們